ERLOTINIB IN NON-SMALL CELL LUNG CANCER: ANALYSIS OF TOXICITY AND EFFICACY IN CLINICAL PRACTICE

被引：0
|
作者：
Alexandre, Maria Teresa A. [1 ]
Ip, Joana [1 ]
Duarte, Isabel [1 ]
Almodovar, Teresa [1 ]
Da Costa, Jose Duro [1 ]
机构：
[1] Inst Portugues Oncol Lisboa, Lisbon, Portugal
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
Lung cancer; Erlotinib; toxicity;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.24-054
引用
收藏
页码：S1326 / S1327
页数：2
相关论文
共 50 条
  • [31] Non-small Cell Lung Cancer (NSCLC) in Octogenarians in Clinical Practice
    Koyi, Hirsh
    Hillerdal, Gunnar
    Kolbeck, Karl-Gustav
    Brodin, Daniel
    Liv, Per
    Branden, Eva
    ANTICANCER RESEARCH, 2016, 36 (10) : 5397 - 5402
  • [32] Combination of quinacrine and erlotinib overcomes resistance to erlotinib in non-small cell lung cancer
    Dermavvan, Josephine Kam Tai
    Gurova, Katerina
    Pink, John
    Dowlati, Afshin
    De, Sarmishtha
    Naria, Goutham
    Sharma, Neelesh
    Stark, George
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [33] Analysis of the response and toxicity to gefitinib of non-small cell lung cancer
    Konishi, J
    Yamazaki, K
    Kinoshita, I
    Isobe, H
    Ogura, S
    Sekine, S
    Ishida, T
    Takashima, R
    Nakadate, M
    Nishikawa, S
    Hattori, T
    Asahina, H
    Imura, M
    Kikuchi, E
    Kikuchi, J
    Shinagawa, N
    Yokouchi, H
    Munakata, M
    Dosaka-Akita, H
    Nishimura, M
    ANTICANCER RESEARCH, 2005, 25 (1B) : 435 - 441
  • [34] Pembrolizumab toxicity in non-small cell lung cancer: a retrospective analysis
    Keast, Mary
    Button, Mick
    Case, Amy
    Iqbal, Sahar
    Namelo, Clara
    Powell, Ceri
    Powell, James
    Shaw, Paul
    Cox, Samantha
    LUNG CANCER, 2022, 165 : S37 - S38
  • [35] The efficacy and safety of nivolumab in advanced non-small cell lung cancer in clinical practice in Japan: A multicenter analysis.
    Kobayashi, Keigo
    Naoki, Katsuhiko
    Nakachi, Ichiro
    Oyamada, Yoshitaka
    Nakamura, Morio
    Inoue, Takashi
    Tateno, Hiroki
    Sakannaki, Fumio
    Sayama, Koichi
    Terashima, Tsuyoshi
    Ko, Hidefumi
    Nishino, Makoto
    Masuzawa, Keita
    Hasegawa, Hanako
    Manabe, Tadashi
    Arai, Daisuke
    Yasuda, Hiroyuki
    Kawada, Ichiro
    Soejima, Kenzo
    Betsuyaku, Tomoko
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [36] Erlotinib monotherapy in patients with advanced non-small cell lung cancer: An effective approach with low toxicity
    Ardavanis, Alexandros
    Koumna, Stella
    Fragos, Ioannis
    Malliou, Savvoula
    Kyriakou, Flora
    Mantzaris, Ioannis
    Scorilas, Andreas
    Rigatos, Gerassimos
    ANTICANCER RESEARCH, 2008, 28 (4C) : 2409 - 2415
  • [37] Efficacy and safety of nivolumab in patients with non-small cell lung cancer: a retrospective study in clinical practice
    Montana, Marc
    Garcia, Marie-Eve
    Ausias, Nathalie
    Jeanpierre, Marion
    Meiffren, Margaux
    Giorgi, Roch
    Vanelle, Patrice
    Barlesi, Fabrice
    JOURNAL OF CHEMOTHERAPY, 2019, 31 (02) : 90 - 94
  • [38] Gefitinib or Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer
    Shao, Yu-Yun
    Lin, Chia-Chi
    Yang, Chih-Hsin
    DISCOVERY MEDICINE, 2010, 9 (49) : 538 - 545
  • [39] Erlotinib for the treatment of brain metastases in non-small cell lung cancer
    Brower, Jeffrey V.
    Robins, H. Ian
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (07) : 1013 - 1021
  • [40] MicroRNA markers for erlotinib resistance in non-small cell lung cancer
    Nelson, Kristen
    Ranade, Aarati
    Kashey, Trevor
    Kingsley, Chris
    Weiss, Glen
    CANCER RESEARCH, 2009, 69
12345